Skip To Main Content
Hüseyin Akıllı on Muck Rack

Hüseyin Akıllı

As seen in: JAMA Network
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hüseyin

Contact Hüseyin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study

|
By Nicolò Bizzarri, Zoltán Novák, Giulio Ricotta, Mihai Emil Capilna, Diana Giannarelli, Santiago Costa Domingo, Vito Chiantera, David Cibula, Diana Zach, Andrea Miranda, Porfyrios Korompelis, Enrique Chacón, Ignacio Zapardiel, Björn Lampe, Valentyn Svintsitskyi, Olga P Matylevich, Gabrielle van Ramshorst, Cagatay Taskiran, Giuseppe Vizzielli, Matteo Loverro, Francesco Fanfani, Claudia Marchetti, Gwénaël Ferron, Alejandra Martinez Verified, Elodie Gauroy, Leo Kiss, Víctor Lago, Giuseppe Cucinella, Jiri Slama, Viktoria Rosta, Mustafa Zelal Muallem, Ali Kucukmetin, Anna Fagotti, Sahar Salehi, Denis Querleu, Hüseyin Akıllı, Fuat Demirkıran, Tibor Lengyel, Emmanuel Ladanyi, Manel Montesinos-Albert
| JAMA Network Verified
Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study Introduction Prognostic factors affecting survival in patients undergoing pelvic exenteration for gynecologic cancers have been reported by the Complications and Recurrence After Pelvic Exenteration (COREPEX) study.1 Previous studies identified a negative association of nodal metastasis with survival of patients undergoing pelvic exenteration1-3 but not improved survival with...
Open in Who Shared Issue with article?
See all 1 articles